No cases of later occurrence of theIDH1 mutation after the TP53 mutation orcodeletion were noted, which allows us to conclude that the IDH1mutation appears at the earliest stages of oncogenesis and that it ispossibly the common early event in the pathogenesis of gliomas of varioushistological variants. The gene discussed is TP53; the disease is central nervous system cancer.